PubMed
Growth hormone-releasing peptide-6 stimulates GH, ACTH, and cortisol release
Arvat et al., 1998
Growth Hormone Releasing Peptide-6
GHRP-6 is a synthetic hexapeptide growth hormone secretagogue that strongly stimulates GH release through ghrelin receptor activation. It is particularly notable for significantly increasing appetite via ghrelin pathway activation — useful in research contexts for body composition changes, catabolic state reversal, and GH deficiency studies. Not FDA-approved for therapeutic use. PeptIQ does not sell peptides or list vendors.
Overall check-ins
Trackers & reports
Overview
GHRP-6 is a synthetic hexapeptide growth hormone secretagogue that strongly stimulates GH release through ghrelin receptor activation. It is particularly notable for significantly increasing appetite via ghrelin pathway activation — useful in research contexts for body composition changes, catabolic state reversal, and GH deficiency studies. Not FDA-approved for therapeutic use. PeptIQ does not sell peptides or list vendors.
Community
From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Favorable 83% · Mixed 17% · Unfavorable overall 0%
Benefits users selected when logging a favorable or mixed check-in.
Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Median bucket: 200–400 mcg · Most common: 200–400 mcg
Reports span 100–400 mcg
Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.
Research
PubMed
Arvat et al., 1998
PubMed
Ghigo et al., 2008
Tools
More ways to learn about GHRP-6 from observational PeptIQ data.
Compare with
Related peptides
Help
This page summarizes 6 anonymized self-reports from PeptIQ users who track GHRP-6, including commonly reported effects and co-tracked peptides. These are observational patterns, not clinical outcomes.
PeptIQ separates overall check-in ratings (favorable, mixed, or unfavorable) from logged side effects like nausea or fatigue. Users often report benefits and side effects in the same check-in — a high experience score does not mean zero side effects were noted.
2 sources are linked on this page, including PubMed articles, clinical trial registries, and FDA labels where applicable. Citations describe published research — not recommendations.
This wiki does not assess safety or recommend use. GHRP-6 is listed as Research Only. Consult a licensed clinician for personal medical decisions.
This wiki summarizes observational community reports and linked citations for GHRP-6. It does not assert therapeutic benefits. See the cited research list on this page and the educational profile for GHRP-6 for study-level context — not medical advice.
GHRP-6 is listed in PeptIQ as Research Only. Regulatory status varies by jurisdiction and can change. This wiki does not provide legal advice; check current FDA and local rules and talk with a licensed clinician or counsel for personal decisions.
Safety data quality for GHRP-6 varies widely by compound and study design. PeptIQ does not establish a risk profile here. Review primary literature, product labeling where applicable, and clinician guidance. Community self-reports are not a substitute for clinical evidence.
This page links 2 indexed sources for GHRP-6. Evidence maturity differs by application — some peptides have large human programs, others are mostly preclinical. Treat citation counts as literature volume, not proof of efficacy.